EGFR and neoplasm: GEM enhanced the protein levels of c-CBL E3 ubiquitin ligase and triggered the ubiquitination and degradation of the epidermal growth factor receptor (EGFR), thereby reducing the downstream functions of EGFR, including tumor cell proliferation, angiogenesis and metastasis.